Literature DB >> 17787014

Identification of age-structured models: cell cycle phase transitions.

E Sherer1, E Tocce, R E Hannemann, A E Rundell, D Ramkrishna.   

Abstract

A methodology is developed that determines age-specific transition rates between cell cycle phases during balanced growth by utilizing age-structured population balance equations. Age-distributed models are the simplest way to account for varied behavior of individual cells. However, this simplicity is offset by difficulties in making observations of age distributions, so age-distributed models are difficult to fit to experimental data. Herein, the proposed methodology is implemented to identify an age-structured model for human leukemia cells (Jurkat) based only on measurements of the total number density after the addition of bromodeoxyuridine partitions the total cell population into two subpopulations. Each of the subpopulations will temporarily undergo a period of unbalanced growth, which provides sufficient information to extract age-dependent transition rates, while the total cell population remains in balanced growth. The stipulation of initial balanced growth permits the derivation of age densities based on only age-dependent transition rates. In fitting the experimental data, a flexible transition rate representation, utilizing a series of cubic spline nodes, finds a bimodal G(0)/G(1) transition age probability distribution best fits the experimental data. This resolution may be unnecessary as convex combinations of more restricted transition rates derived from normalized Gaussian, lognormal, or skewed lognormal transition-age probability distributions corroborate the spline predictions, but require fewer parameters. The fit of data with a single log normal distribution is somewhat inferior suggesting the bimodal result as more likely. Regardless of the choice of basis functions, this methodology can identify age distributions, age-specific transition rates, and transition-age distributions during balanced growth conditions. Copyright 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17787014     DOI: 10.1002/bit.21633

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  7 in total

1.  In vitro ovine articular chondrocyte proliferation: experiments and modelling.

Authors:  L Mancuso; M I Liuzzo; S Fadda; M Pisu; A Cincotti; M Arras; G La Nasa; A Concas; G Cao
Journal:  Cell Prolif       Date:  2010-04-14       Impact factor: 6.831

2.  Experimental analysis and modelling of in vitro HUVECs proliferation in the presence of various types of drugs.

Authors:  L Mancuso; M Scanu; M Pisu; A Concas; G Cao
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

Review 3.  Scalable stirred-suspension bioreactor culture of human pluripotent stem cells.

Authors:  Daniel E Kehoe; Donghui Jing; Lye T Lock; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

4.  Experimental analysis and modelling of in vitro proliferation of mesenchymal stem cells.

Authors:  L Mancuso; M I Liuzzo; S Fadda; M Pisu; A Cincotti; M Arras; E Desogus; F Piras; G Piga; G La Nasa; A Concas; G Cao
Journal:  Cell Prolif       Date:  2009-07-10       Impact factor: 6.831

5.  A checkpoint-oriented cell cycle simulation model.

Authors:  David Bernard; Odile Mondesert; Aurélie Gomes; Yves Duthen; Valérie Lobjois; Sylvain Cussat-Blanc; Bernard Ducommun
Journal:  Cell Cycle       Date:  2019-04-04       Impact factor: 4.534

Review 6.  Deconstructing stem cell population heterogeneity: single-cell analysis and modeling approaches.

Authors:  Jincheng Wu; Emmanuel S Tzanakakis
Journal:  Biotechnol Adv       Date:  2013-09-11       Impact factor: 14.227

7.  Quantifying the length and variance of the eukaryotic cell cycle phases by a stochastic model and dual nucleoside pulse labelling.

Authors:  Tom Serge Weber; Irene Jaehnert; Christian Schichor; Michal Or-Guil; Jorge Carneiro
Journal:  PLoS Comput Biol       Date:  2014-07-24       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.